Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Activation of innate immunity and deposition of blood-derived fibrin in the central nervous system (CNS) occur in autoimmune and neurodegenerative diseases, including multiple sclerosis (MS) and Alzheimer's disease (AD). However, the mechanisms that link disruption of the blood-brain barrier (BBB) to neurodegeneration are poorly understood, and exploration of fibrin as a therapeutic target has been limited by its beneficial clotting functions. Here we report the generation of monoclonal antibody 5B8, targeted against the cryptic fibrin epitope γ 377-395, to selectively inhibit fibrin-induced inflammation and oxidative stress without interfering with clotting. 5B8 suppressed fibrin-induced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation and the expression of proinflammatory genes. In animal models of MS and AD, 5B8 entered the CNS and bound to parenchymal fibrin, and its therapeutic administration reduced the activation of innate immunity and neurodegeneration. Thus, fibrin-targeting immunotherapy inhibited autoimmunity- and amyloid-driven neurotoxicity and might have clinical benefit without globally suppressing innate immunity or interfering with coagulation in diverse neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fggγ390–396A reduces AD-related pathogenesis, including amyloid burden, dystrophic neurites, synaptic loss, microgliosis, and neuroinflammation in 5xFAD-Fggγ390–396A mice relative to 5xFAD mice.21,22,34”
From Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models (2024) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which is upregulated in neurodegenerative diseases (Haslund-Vinding et al., 2017; Lassmann, 2011; Ryu et al., 2018).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Ryu et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, a fibrin-targeting antibody that selectively inhibits microglia activation without adverse anticoagulant effects protects from neurodegeneration and suppresses AD-related gene networks in 5xFAD mice.28,34”
From Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models (2024) · cites this paper as [34]
In the citing paper
“Fibrinogen-induced CD11b/CD18 receptor-mediated microglia activation instigates the generation and release of neurotoxic reactive oxygen species (ROS) via nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which is upregulated in neurodegenerative diseases (Haslund-Vinding et al., 2017; Lassmann, 2011; Ryu et al., 2018).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Ryu et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Warde-Farley, D., Donaldson, S. L., Comes, O., Zuberi, K., Badrawi, R., Chao, P., Franz, M., Grouios, C., Kazi, F., Lopes, C. T., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq537 · Cited by 4,835
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00084-2 · Cited by 3,042
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Research works printed but not linked: 1
- Davalos D Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 3, 1227 (2012). 23187627 PMC3514498
Cited by
Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions
Magid-Bernstein, J., Girard, R., Polster, S., Srinath, A., Romanos, S., Awad, I. A., & Sansing, L. H. (2022) · Circulation Research · doi:10.1161/circresaha.121.319949 · Cited by 666
Merlini, M., Rafalski, V. A., Rios Coronado, P. E., Gill, T. M., Ellisman, M., Muthukumar, G., Subramanian, K. S., Ryu, J. K., Syme, C. A., Davalos, D., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.014 · Cited by 431
Self-citationMeningeal lymphatics affect microglia responses and anti-Aβ immunotherapy
Da Mesquita, S., Papadopoulos, Z., Dykstra, T., Brase, L., Farias, F. G., Wall, M., Jiang, H., Kodira, C. D., de Lima, K. A., Herz, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03489-0 · Cited by 431
Emerging diagnostics and therapeutics for Alzheimer disease
Self, W. K., & Holtzman, D. M. (2023) · Nature Medicine · doi:10.1038/s41591-023-02505-2 · Cited by 381
The immunology of multiple sclerosis
Attfield, K. E., Jensen, L. T., Kaufmann, M., Friese, M. A., & Fugger, L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00718-z · Cited by 380
Metadata
- Authors
- Ryu, J. K., Rafalski, V. A., Meyer-Franke, A., Adams, R. A., Poda, S. B., Rios Coronado, P. E., Pedersen, L. Ø., Menon, V., Baeten, K. M., Sikorski, S. L., Bedard, C., Hanspers, K., Bardehle, S., Mendiola, A. S., Davalos, D., Machado, M. R., Chan, J. P., Plastira, I., Petersen, M. A., Pfaff, S. J., Ang, K. K., Hallenbeck, K. K., Syme, C., Hakozaki, H., Ellisman, M. H., Swanson, R. A., Zamvil, S. S., Arkin, M. R., Zorn, S. H., Pico, A. R., Mucke, L., Freedman, S. B., Stavenhagen, J. B., Nelson, R. B., & Akassoglou, K.
- Affiliations
- Gladstone Institutes (US)
- University of California San Diego (US)
- Lundbeck (Denmark) (DK)
- Cleveland Clinic (US)
- University of California, San Francisco (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Akassoglou, Katerina
- ORCID
- Ryu, Jae Kyu
- Adams, Ryan A.
- Poda, Suresh B.
- Menon, Veena
- Baeten, Kim M.
- Hanspers, Kristina
- Mendiola, Andrew S.
- Davalos, Dimitrios
- Chan, Justin P.
- Plastira, Ioanna
- Petersen, Mark A.
- Pfaff, Samuel J.
- Hallenbeck, Kenneth K.
- Syme, Catriona
- Hakozaki, Hiroyuki
- Ellisman, Mark H.
- Swanson, Raymond A.
- Zamvil, Scott S.
- Arkin, Michelle R.
- Pico, Alexander R.
- Mucke, Lennart
- Freedman, Stephen B.
- Nelson, Robert B.
- Akassoglou, Katerina
- Venue
- Nature Immunology
- Published
- 2018-10-15
- Volume
- 19
- Issue
- 11
- Pages
- 1212-1223
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC6317891
- OpenAlex
- W2896105679
- Cited by
- 213
- References
- 67
- Citations by year
- 2026: 21 · 2025: 21 · 2024: 37 · 2023: 25 · 2022: 29 · 2021: 36 · 2020: 21 · 2019: 20 · 2018: 3
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Science Foundation (0648991, 1144247)
- National Multiple Sclerosis Society (RG1701‐26628, FG-1708-28925)
- Conrad N. Hilton Foundation (17348)
- American Heart Association
- S. D. Bechtel, Jr. Foundation and Stephen Bechtel Fund
- Gladstone Institutes (RR18928)
- Multiple Sclerosis Society
- H. Lundbeck A/S
- National Institutes of Health (5k12hd072222-05, 1c06rr018928-01, CA082103, P41 GM10341)
- University of California, San Francisco
- National Cancer Institute (P30CA082103)
- National Institute of General Medical Sciences (T32GM007175)
- National Institute of Allergy and Infectious Diseases (T32AI007334)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090382)
- National Institute of Neurological Disorders and Stroke (R01NS081149, NS082976, NS096920, NS052189, R21NS082976, R21NS108159, R35NS097976, R01NS052189, F32NS096920, NS097976, R01NS092835, NS081149)
- National Center for Research Resources (C06-RR-018928, RR18928)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12-HD072222, P01HD084387)
- Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- neuroinflammation, neurodegeneration, multiple sclerosis, Alzheimer's disease, blood-brain barrier disruption, innate immunity, NADPH oxidase, oxidative stress, fibrin deposition, coagulation
- MeSH terms
- Animals, Antibodies, Monoclonal, Epitopes, Fibrinogen, Humans, Inflammation, Neurodegenerative Diseases, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. https://app.cochat.ai/papers/10.1038/s41590-018-0232-x
- The paper
- Ryu, J. K., Rafalski, V. A., Meyer-Franke, A., Adams, R. A., Poda, S. B., Rios Coronado, P. E., Pedersen, L. Ø., Menon, V., Baeten, K. M., Sikorski, S. L., Bedard, C., Hanspers, K., Bardehle, S., Mendiola, A. S., Davalos, D., Machado, M. R., Chan, J. P., Plastira, I., Petersen, M. A., . . . Akassoglou, K. (2018). Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nature Immunology. https://doi.org/10.1038/s41590-018-0232-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.